Microproteinuria: Indicator to monitor CNI-related nephrotoxicity in liver transplant recipients?June 29th, 2009 in Medicine & Health / Diseases, Conditions, Syndromes
Deterioration of renal function with CNI therapy has been widely reported in liver transplant recipients. Microproteinuria has been used to monitor the early changes of nephropathy in renal disease or cardiovascular events. However, whether microproteinuria could be used as an early and sensitive indicator to monitor CNI-related nephrotoxicity in liver transplant recipients has not been unequivocally addressed.
A research article to be published in June 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Yan from West China Hospital of Sichuan University studied the use of microproteinuria in early diagnosis of CNI-related nephrotoxicity after liver transplantation. Measurements of microproteinuria including Alpha-1-microglobulin (Alpha-1m), β2-microglobulin (β2m), immunoglobulin, microalbumin and transferrin were performed with a Dade Behring array nephelometry system.
Follow-up data of this study demonstrated that there was a downward trend in renal function over time, with the persistence of microproteinuria. The urinary concentration of β2m and Alpha-1m significantly increased with the subtle changes in renal function in the study groups, but the levels of SCr and BUN significantly increased only when renal function was severely damaged by CNI nephrotoxicity. The subsequent reductions in GFR were closely correlated with the increases in Alpha-1m and β2m. Fewer patients were found to have β2m in the urine than Alpha-1m in this study as β2m is unstable in fresh urine. This problem can partly be overcome by maintaining the urine pH value (by adding basic buffer to the urine) to prevent the degradation of β2m.
This study suggested that urinary β2m and Alpha-1m are sensitive urinary markers for detecting CNI-related nephrotoxicity in liver transplant recipients. The results are interesting and may represent a screening method to prevent the progression of CNI-related subclinical renal dysfunction after liver transplantation.
More information: Li J, Liu B, Yan LN, Wang LL, Lau WY, Li B, Wang WT, Xu Q, Yang JY, Li FG. Microproteinuria for detecting calcineurin nhibitor-related nephrotoxicity after liver transplantation. World J Gastroenterol 2009; 15(23): 2913-2917. http://www.wjgnet.com/1007-9327/15/2913.asp
"Microproteinuria: Indicator to monitor CNI-related nephrotoxicity in liver transplant recipients?." June 29th, 2009. http://phys.org/news165488685.html